Marshall Wace, LLP Bioventus Inc. Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Bioventus Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 211,695 shares of BVS stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

211,695

Previous 159,744 32.52%

Holding current value

$1.43 Million

Previous $1.46 Million 4.11%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.2 - $9.51 $322,096 - $494,054	51,951 Added 32.52%	211,695 $1.4 Million
Q1 2025 May 15, 2025	BUY	$8.76 - $11.05 $756,171 - $953,847	86,321 Added 117.57%	159,744 $1.46 Million
Q4 2024 Feb 13, 2025	SELL	$10.5 - $13.71 $3.23 Million - $4.21 Million	-307,404 Reduced 80.72%	73,423 $770,000
Q3 2024 Nov 14, 2024	BUY	$5.73 - $11.95 $278,111 - $580,005	48,536 Added 14.61%	380,827 $4.55 Million
Q2 2024 Aug 14, 2024	BUY	$3.96 - $6.93 $363,698 - $636,471	91,843 Added 38.2%	332,291 $1.91 Million
Q1 2024 May 15, 2024	BUY	$4.33 - $5.75 $215,690 - $286,424	49,813 Added 26.13%	240,448 $1.25 Million
Q4 2023 Feb 14, 2024	SELL	$2.89 - $5.34 $214,767 - $396,836	-74,314 Reduced 28.05%	190,635 $1 Million
Q3 2023 Nov 14, 2023	BUY	$2.8 - $4.94 $543,698 - $959,239	194,178 Added 274.38%	264,949 $874,000
Q2 2023 Aug 14, 2023	BUY	$0.93 - $3.64 $65,817 - $257,606	70,771 New	70,771 $204,000
Q2 2022 Aug 15, 2022	SELL	$6.82 - $13.82 $71,200 - $144,280	-10,440 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.65 - $15.28 $1.92 Million - $2.52 Million	-164,751 Reduced 94.04%	10,440 $147,000
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $2.17 Million - $2.94 Million	175,191 New	175,191 $2.54 Million
Q2 2021 Aug 13, 2021	SELL	$13.75 - $18.8 $285,395 - $390,212	-20,756 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.49 - $19.21 $238,486 - $398,722	20,756 New	20,756 $317,000

Others Institutions Holding BVS

# of Institutions

147

Shares Held

49.3M

Call Options Held

85.1K

Put Options Held

13K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $417M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Bioventus Inc. Transaction History